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ABSTRACT The high specificity of bacteriophages is driven by their receptor-bind-
ing proteins (RBPs). Many Klebsiella bacteriophages target the capsular exopolysac-
charide as the receptor and encode RBPs with depolymerase activity. The modular
structure of these RBPs with an N-terminal structural module to attach the RBP to
the phage tail, and a C-terminal specificity module for exopolysaccharide degrada-
tion, supports horizontal transfer as a major evolutionary driver for Klebsiella phage
RBPs. We mimicked this natural evolutionary process by the construction of modular
RBP chimeras, exchanging N-terminal structural modules and C-terminal specificity
modules. All chimeras strictly follow the capsular serotype specificity of the C-termi-
nal module. Transplanting chimeras with a K11 N-terminal structural RBP module in
a Klebsiella phage K11 scaffold results in a capsular serotype switch and correspond-
ing host range modification of the synthetic phages, demonstrating that horizontal
transfer of C-terminal specificity modules offers Klebsiella phages an evolutionary
highway for rapid adaptation to new capsular serotypes.
IMPORTANCE The antimicrobial resistance crisis has rekindled interest in bacterio-
phage therapy. Phages have been studied over a century as therapeutics to treat
bacterial infections, but one of the biggest challenges for the use of phages in thera-
peutic interventions remains their high specificity. In particular, many Klebsiella
phages have a narrow spectrum constrained by the high diversity of exopolysacchar-
ide capsules that shield access to the cells. In this work, we have elaborated how
Klebsiella phages deal with this high diversity by exchanging building blocks of their
receptor-binding proteins.
KEYWORDS bacteriophage, Klebsiella, depolymerase, horizontal transfer, receptor-
binding protein
Bacteriophages infect bacteria with high specificity. A major determinant for thisspecificity is located in the phage-encoded receptor-binding proteins (RBPs) that
structure phage tail fibers and/or tail spikes. RBPs mediate the initial contact of the
phage with their cognate receptors on the host cell surface and are essential to initiate
the infection process (1–3). Many Klebsiella phages target the capsular exopolysacchar-
ide as an initial receptor. Their RBPs show depolymerase activity, actively binding and
degrading the capsule (4). Klebsiella strains show a large capsular diversity with at least
79 serotypes reported today, each having a different polysaccharide composition (5),
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and the RBP diversity is correspondingly high. Phage RBPs are generally specific for a
single (or a few) serotype(s), and the relationship between RBP specificity, capsular
serotype, and phage host spectrum has been extensively demonstrated for wild-type
phages (6–15). The number of RBPs with depolymerase activity per phage is highly
variable. Phage KP36 produces a single RBP and is only active against serotype K63,
corresponding to the substrate specificity of its RBP (8, 16), whereas other phages (e.g.,
KP32, K5-2, K5-4, and UK64-1) encode more RBPs with depolymerase activity, recogniz-
ing a corresponding number of capsular serotypes (6, 7, 9, 10, 17) and resulting in a
broader host spectrum. A similar relationship has also been described for Escherichia
coli and Salmonella phages (18–20).
Klebsiella phage RBPs typically have a modular structure with N-terminal module(s)
dedicated to structural organization and attachment of the RBP to the phage tail struc-
ture, while C-terminal modules are generally involved in receptor binding and degra-
dation (16). Some RBPs comprise an additional C-terminal chaperone for proper folding
and trimerization, followed by autoproteolytic cleavage (21–25). This modular build-up
of RBPs is shaped by intense horizontal transfers (26, 27). Further accumulation of
mutations (vertical transfer) has magnified the diversity of the polysaccharide-degrad-
ing enzymatic domains (4, 19, 23, 28–30). In our previous work, the RBP architectures
of 59 Klebsiella phages spread over six taxonomic groups have been analyzed along
with suggested evolutionary linkages between the different RBP organizations (16).
Horizontal transfer appears to be the major evolutionary force to drive host adaptation
in a broad range of Klebsiella phages. To mimic this natural evolutionary process on a
laboratory scale, we constructed and evaluated modular chimeras, exchanging N-ter-
minal structural modules and C-terminal specificity determinants. In addition, we con-
structed synthetic phages with these functional chimeras, confirming that horizontal
transfer can drive serotype specificity and host range switching in Klebsiella phages.
RESULTS
The capsule serotype specificity of chimeric RBPs follows the C-terminal
depolymerase domain. Klebsiella phages KP32, KP34, and KP36 were selected as rep-
resentatives of well-characterized Klebsiella phage groups. Their RBPs with depolymer-
ase activity were identified and characterized previously (8, 9, 31), and their RBP archi-
tectures differ significantly (16) (see Fig. 2A). Phage KP32 has two RBPs, with a first RBP
connected to the phage tail via an N-terminal anchor domain (1A), while the second
RBP (2E) interacts with the first RBP (31). Podovirus KP34 has a single RBP (3E) indirectly
attached to the virion via an intermediate anchor protein (3A), and siphovirus KP36 has
a single RBP, including an N-terminal anchor domain (4A) for direct attachment to the
phage particle. The two depolymerase domains of phage KP32 (1E and 2E) have a K3
and K21 capsular specificity, respectively, whereas the single RBP of phages KP34 (3E)
and KP36 (4E) are both specific to the K63 serotype. The depolymerase domain of
phage KP34 (3E) and phage KP36 (4E) share 42% identity in amino acid sequence. This
high similarity suggests an evolutionary linkage across morphotype borders (podovi-
rus/siphovirus), resulting from a horizontal transfer followed by vertical evolution
through the accumulation of mutations.
Each possible chimera recombining an anchor domain (1A, 3A, and 4A) and an en-
zymatic domain (1E, 2E, 3E, and 4E) of the three different phages were produced,
resulting in 12 combinations. In addition, we also produced four chimeras using the
corresponding anchor domain (5A) of the well-studied K. pneumoniae phage K11.
Phage K11 clusters taxonomically with phage KP32. The VersaTile technique (32) was
used to produce the sequences for the chimeras, since this technique is dedicated to
the convenient assembly of nonhomologous building blocks, such as anchor and enzy-
matic domains. A three-position design was chosen. At first, all building blocks to be
recombined were converted to so-called tiles by flanking them with 6-nucleotide (nt)
position tags. Anchor (1A, 3A, 4A, and 5A) and enzymatic (1E, 2E, 3E, and 4E) domain
sequences are labeled for positions 1 and 2, respectively, whereas a hexahistidine tag
was labeled for position 3 (Fig. 1 and 2B). The delineation of the anchor and enzymatic
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domains was guided by the crystal structure of the tail spike of Salmonella phage P22,
showing a prominent physical separation between the anchor and enzymatic domain
by an extended a-helix. Therefore, each anchor domain was delineated after its long
a-helix, as in the P22 tail spike (Fig. 2D; see also Fig. S1 in the supplemental material).
Secondly, all coding sequences of 16 chimeras were constructed by combining the re-
spective tiles in a VersaTile assembly reaction (Fig. 2C). The used destination vector
(pVTD2) was a high-copy-number vector with a T7 promoter for expression in E. coli.
All 16 chimeras were successfully expressed in a small-scale culture (10ml) (Fig. S2
and Table S3). Lysates were spotted on lawns of K. pneumoniae clinical strains with
defined capsular serotypes (K3, K21, and K63) to examine the enzymatic activity and
specificity of the chimeric proteins (Fig. S3). Control proteins included purified stocks
of the full-length wild-type RBPs of phage KP32 (1AE WT and 2E WT), phage KP34 (3A
WT and 3E WT), and phage KP36 (4AE WT). In addition, the separate enzymatic
domains (1E and 4E) were expressed. All spotted proteins caused a semitransparent
halo, demonstrating decapsulating enzymatic activity, except for 3A WT, which lacks
an enzymatic domain (Fig. 3). The capsular serotype specificity always followed the
original specificity of the enzymatic domain of the chimera, regardless of the anchor
fusion partner. For example, the 1AE wild-type protein and 1E domain are active on a
strain with the K3 serotype, corresponding to the phage host specificity; consistent
with this, all chimeras bearing 1E were only active on the K3 serotype as well.
Enzymatic domains that have no natural anchor domain (2E and 3E) also retain their
activity and capsule serotype specificity upon fusion to a noncognate anchor domain.
Note that taxonomic borders were crossed in some chimera. For example, 1A1 4E
combines an anchor domain of podovirus KP32 and an enzymatic domain of siphovi-
rus KP36. This suggests that the evolution of RBPs can be successful by horizontal
transfer across phage families.
Since we observed that 1AE releases its C-terminal chaperone domain during
expression by autoproteolytic cleavage, we also evaluated the 1E domain without its
chaperone. The protein could be expressed but only in the insoluble fraction, and it
FIG 1 VersaTile method. Tiles provided with position tags corresponding to positions 1, 2, and 3 are
cloned in the pVTEIII entry vector. Subsequently, they are mixed with the pVTD2 destination vector
(possessing the sacB gene as a negative selective marker). This mixture is subjected to restriction
(BsaI) and ligation (T4 DNA ligase) cycles in one tube. Tiles are subsequently assembled into the
destination vector pVTD2 in the designed order according to the position tags.
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did not show any enzymatic activity, stressing the role of the chaperone domain for
correct folding (Fig. 3).
Synthetic phages with chimeric RBPs are infective and follow the serotype
specificity of the swapped RBP. All chimeras were found to be enzymatically active,
demonstrating that the delineation of domains did not disrupt the enzymatic activity.
Moreover, the chimeric proteins were able to fold properly despite possessing a non-
cognate N-terminal anchor. Consistent with the prediction, the enzymatic specificity of
the chimera strictly correlates to the specificity of its enzymatic domain. Thus, the
FIG 2 Modular architecture of Klebsiella phage RBPs and their chimeras. (A) Overview of the genomic context
of the RBPs of phages KP32, KP34, KP36, and K11, along with their modeled RBP architectures. The different
anchor domains are labeled A, preceded by the protein number. This A domain is predicted to anchor the RBP
to the virion, and all anchor domains differ substantively in amino acid sequence, except for 1A and 5A, which
share 88% similarity at the amino acid level. The enzymatic domains with depolymerase activity are labeled E,
preceded by the protein number. The colors correspond to the capsule serotype specificity. The first and
second RBP of phage KP32 are KP32gp37 (YP_003347555.1) and KP32gp38 (YP_003347556.1). The intermediate
anchor protein and the RBP of phage KP34 are KP34gp49 (YP_003347643.1) and KP34gp57 (YP_003347651.1),
respectively, whereas the single RBP of phage KP36 is KP36gp50 (YP_009226011.1). The white blocks in phage
KP34 correspond to intervening, non-RBP genes. The RBP structure of phage K11 (belonging to group A of the KP32
viruses, Przondovirus; 16, 35–37) follows a pattern similar to that of phage KP32 with a first (K11gp17; YP_002003830
.1) and second (K11 ASC_0043; YP_002003831.1) RBP. (B) Preparation of a tile repository. Each tile contains a coding
sequence for either an anchor or enzymatic domain, flanked by position tags for position 1 (anchors), position 2
(enzymatic domains), and position 3 (hexahistidine tag for protein purification). (C) Overview of the chimeric RBPs
combining cognate and noncognate anchor (position 1) and enzyme (position 2) domains, followed by a C-terminal
hexahistidine tag (position 3). (D) The tail spike of Salmonella phage P22 (PDB entry 2XC1) illustrates a typical
modular RBP structure and guided the construction of chimeras. The RBP has an N-terminal dome-like anchor
domain (A), a central b-helical domain for host recognition and enzymatic activity, and a C-terminal domain
responsible for protein trimerization and/or receptor recognition (E) (24, 54, 55). The tiles corresponding to the
anchor domains (1A, 3A, 4A, and 5A) included both the N-terminal dome-like domain and the long a-helix that
physically separates both functions of the RBP (red frame), while the tiles of the enzymatic domains 1E, 4E, and 5E
combine the remaining parts (green frame). Phyre2 analyses were used to predict the long a-helix in 1A, 3A, 4A,
and 5A. Based on this prediction, the anchor domain ends were delineated after 178, 170, 135, and 178 aa for 1A,
3A, 4A, and 5A, respectively.
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enzymatic domains behave as true modules having an autonomous folding and auton-
omous function, two prerequisites for a successful horizontal transfer. To evaluate
whether the anchor domains also conserve their autonomous folding and function,
i.e., anchoring of the RBP to the phage particle, we constructed and evaluated syn-
thetic phages with the original RBP replaced by a chimeric RBP. In addition, we
assessed the presence (or absence) of capsular serotype specificity switches.
We used the phage engineering platform in S. cerevisiae based on the yeast gap
repair system to assemble synthetic phage genomes in a yeast artificial chromosome
(YAC), followed by electroporation of E. coli cells with the isolated YAC for rebooting of
the assembled phage genomes (33). As a first step to evaluate this phage engineering
platform for our purposes, we used isolated wild-type genomic DNA of Klebsiella phage
KP32 for electroporation of E. coli 10G cells. The cells were lysed to release the
rebooted synthetic phages, and the lysate was plated on the respective Klebsiella host
strain. Plaques were formed thus, infective KP32 phages could be rebooted in a nonna-
tural host by electroporation. However, in vivo assembly of the same phage genome in
YAC and subsequent rebooting was unsuccessful. One reason might be the low yield
of successfully assembled YAC DNA in combination with a low transformation effi-
ciency. Therefore, we used K. pneumoniae phage K11 as an engineering scaffold, the
genome of which was successfully assembled and rebooted before (33) and in this
study (Fig. S4). Phage K11 belongs to group A of Przondovirus and has a high identity
at the genome level with phage KP32 (91% identity with a query coverage of 88%).
One RBP (K11gp17; 5AE) with depolymerase activity against capsular serotype K11 has
been reported before (34), but based on our previous in silico analysis, a second RBP
(K11 ASC_0043; 6E) with a putative depolymerase activity was predicted (Fig. 2A) (16).
Protein K11 ASC_0043 has been recombinantly produced, but its capsular specificity
FIG 3 Capsule serotype specificity of chimeric RBPs. All chimeras and control proteins were
expressed and examined on bacterial lawns of Klebsiella strains with the K3 serotype (host of phage
KP32), K21 serotype (host of phage KP32), and K63 serotype (host of phages KP34 and KP36). The
chimeric proteins (Table S3) and their modular structure are represented in different colors and
shades. The presence of visible halos on a particular strain is highlighted. In all cases, there was a
strict correlation between the enzymatic domain (when present) and the capsule serotype, except
when the chaperone domain was deleted in 1E and when using the 3A wild-type protein, which has
only an anchoring function and no enzymatic domain. A plus sign between domains in the code
name means that the chimeric protein is the result of VersaTile assembly. When there is no plus sign
between the anchor (A) and enzyme (E) domain (for example, 1AE WT), the wild-type (WT)
depolymerase was prepared, as done for the native sequence, without a cloning scar between the
anchor and enzyme domain. VersaTile-assembled chimeras have an intervening linker of two amino
acids between both domains, resulting from the position tag.
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has not been found, despite screening a broad collection of Klebsiella capsular sero-
types (n=79). The first RBPs of phage K11 and KP32, K11gp17 and KP32gp37, respec-
tively, share 88% identity in their N termini (157/178 amino acids [aa]). However, the re-
mainder of the protein comprising the enzymatic domain is distinct, explaining why
phage K11 does not infect KP32 host K. pneumoniae 271 (K3) but targets capsule sero-
type K11 instead.
Given the high identity (88%) between the anchor domains of the first RBPs of
phage KP32 (1A) and K11 (5A), we first exchanged the K11gp17 anchor (5A) with the
KP32gp37 anchor (1A) while conserving the native enzymatic domain of the first RBP
of phage K11. Thus, a chimeric RBP (1A1 5E) was transplanted in a phage K11 scaffold,
resulting in K111A5E (Fig. 4). Infective phage particles of K111A5E were successfully
rebooted and were specific to K. pneumoniae 390 (capsular serotype K11) only, a wild-
type K11 host (Fig. 5). These observations support that the anchor domain of the first
RBP of phage KP32 is a true module with autonomous folding, independent of its
neighboring domain, and has an autonomous function, i.e., attachment of the RBP to
the phage tail. True modules can be most easily exchanged by horizontal transfer.
Subsequently, we aimed to modify the specificity of phage K11 by mimicking a hor-
izontal transfer between phages K11 and KP32, both belonging to the Przondovirus ge-
nus. The enzyme domains of the first RBPs of phage K11 (5E) and phage KP32 (1E)
were switched in a phage K11 scaffold, resulting in engineered phage K115A1E (Fig. 4).
The rebooted modified phage was able to form plaques on K. pneumoniae 271 (sero-
type K3) and no longer on K. pneumoniae 390 (serotype K11) (Fig. 5 and Fig. S4).
Analogously, the construction of phage K11 equipped with the anchor domain (1A)
and the enzymatic domain (1E) of the first RBP of phage KP32 (K111A1E; Fig. 4 and 5) led
FIG 4 Modifications of phage K11. (A) Overview of synthetic K11 phages with a chimeric RBP
constructed in this work in the order of appearance in the text. (B) Synthetic phage K115A4E could not
be successfully rebooted. The subscripts indicate the chimeric RBP that replaces the native first RBP
of phage K11 (K11gp17) (Tables S3 and S4). The second putative RBP of phage K11 is shown
transparently because its presence could not be confirmed experimentally, as its receptor is
unknown.
FIG 5 Specificity of the constructed synthetic phages against Klebsiella strains with different capsular
serotypes. The construction of synthetic phages is presented in Table S4 with the respective codes.
WT, wild-type phage.
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to the same shift to the K3 host, confirming again the exchangeability of the phage
K11 and phage KP32 anchors.
Next, we transferred the second RBP of phage KP32 (KP32gp38; 2E) as a substitute
for the enzymatic part of K11gp17 (5E) while conserving the wild-type anchor (5A).
This modified phage (K115A2E) became accordingly specific for the K21 capsular sero-
type while losing specificity for capsular serotype K11. Similarly, K115A3E, possessing a
chimera of the wild-type phage K11 anchor (5A) and the full depolymerase of phage
KP34 (KP34gp57, 3E), was also successfully rebooted (Fig. S4), resulting in a host range
switch from K. pneumoniae 390 (K11 serotype) to K. pneumoniae 77 and K. pneumoniae
486 (both K63 serotype). Phage K11 (Przondovirus) and phage KP34 (Drulisvirus) are
both podoviruses at the morphological level (16, 35–37) but belong to different taxo-
nomic groups. The enzyme domain of phage KP36 depolymerase (KP36gp50, 4E)
shows a high amino acid similarity (43%) to phage KP34 depolymerase (3E) and shares
specificity for capsular serotype K63. However, phage KP36 belongs to the
Drexlerviridae family (siphoviruses). Any attempt to create the synthetic phage K115A4E,
bearing a chimeric fusion of the KP11gp17 anchor (5A) and the KP36 depolymerase
(KP36gp50, 4E), was unsuccessful despite the fact that an enzymatically active chimera
(5A1 4E) could be produced. Gibson assembly also was evaluated as an alternative
approach to produce the synthetic phage genome but did not result in infective
phages either, suggesting that a horizontal transfer between two distinct phage mor-
photypes (podo- and siphoviruses) is not trivial in this case.
DISCUSSION
In this study, we aimed (i) to evaluate the triangular relationship between capsular
serotype, host spectrum, and depolymerase specificity of Klebsiella phages and (ii) to
mimic horizontal transfer on a laboratory scale as the major evolutionary driver of RBPs
to switch the host spectrum of Klebsiella phages. A two-tiered approach was followed.
First, we evaluated a set of chimeric RBPs for their functionality, which allowed us to
identify transferable, functional units. Secondly, synthetic phages were produced with
chimeric RBPs and their host spectrum was analyzed. The VersaTile technique was
used as a click-and-play method to efficiently construct the coding sequences of chi-
meric proteins (32). The phage engineering platform based on gap repair cloning in S.
cerevisiae and phage rebooting in electroporated E. coli 10G cells (33) was applied to
create synthetic phages.
The construction of chimeric RBPs was based on the former confirmation of the en-
zymatic activity and specificity of the selected model RBPs with a depolymerase do-
main (8, 9, 31). All chimeric RBPs were enzymatically active with a specificity switch cor-
responding to the predicted enzymatic domain. The same specificity switches take
place for synthetic phages bearing these chimeric RBPs, also confirming the role of the
anchor domains. The long a-helix, inspired by the phage P22 RBP tertiary structure (21,
38), appeared to be a good predictor for delineation of the domains without the
availability of crystal structures. These findings give experimental support for the evo-
lution model of phage RBPs being created by horizontal transfers of enzymatic
domains that can be plugged into different RBP architectures regardless of phage ge-
nus (Przondovirus versus Drulisvirus). Whereas the chimera combining the K11gp17
anchor with the enzyme domain of KP36gp50 (5A1 4E) is enzymatically active, using
two different assembly techniques, we did not succeed in obtaining infective K11
phage particles with this enzymatic domain. This hints at an incompatible direct trans-
fer between a siphovirus and a podovirus. However, a natural chimera combining a
myovirus-like anchor and a podovirus-like enzymatic domain has been reported before
(39). In addition, RBP shuffling has been successful across phage families for phage tail-
like bacteriocins (40). Proper virion assembly may be hindered in synthetic phage
K115A4E by differences in virion assembly between podovirus K11 and siphovirus
KP36. In addition, many RBPs need a chaperone domain or additional tail fiber assem-
bly protein for folding and trimerization. A putative tail assembly protein (KP36gp48) is
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identified two genes upstream of the KP36gp50 coding sequence; however, the chi-
meric RBP could be properly expressed as a functional recombinant protein, indicating
correct folding. The putative tail assembly protein is predicted to be responsible for
KP36gp49, which may act as a second side RBP, as in the case of some T5 viruses
(DT57C and DT571) or the central tail tip (16); however, we cannot exclude a role in the
proper assembly of KP36gp50 as well.
Klebsiella phage K11 is 91% identical to phage KP32 (with 88% query coverage) at the
genome level and was eventually chosen as a scaffold for phage engineering. Notably,
phage K11 belongs to Przondovirus (same subgroup as phage KP32; 16, 35–37), which, in
turn, belongs to the Autographiviridae (former T7 supergroup). Ando et al. (33) reported
before on the exchange of the first RBP of phage K11 (K11gp17) with the single tail fiber
of E. coli phage T7 (gp17). Their initial attempts based on a simple exchange did not yield
infective phages. The T7 phage tail is composed of a gp11 dodecamer, forming the adap-
tor, and a gp12 hexamer, forming the nozzle. The adaptor ring is responsible for the
attachment of the preformed tail to the portal (gp8) of the prohead. The interaction
between the tail and the six tail fibers (or RBPs) occurs at the interface of the adaptor and
the nozzle (41, 42). The homology of the adaptor and nozzle between phages T7 and K11
is much lower than the homology of the portal protein between both phages. Therefore,
the coding sequences of the adaptor (K11gp11), the nozzle (K11gp12), and the first RBP
(K11gp17) were simultaneously exchanged in phage K11 for the equivalents of phage T7,
resulting in K11 phage particles infecting E. coli. In contrast to the RBP of phage T7, the
first RBP of phage KP32 could be simply transferred into phage K11 (88% similarity at the
anchor level). Both phage K11 with a chimera of the phage K11 anchor and the phage
KP32 enzymatic domain (K115A1E), as well as phage K11 with the full RBP of phage KP32
(K111A1E), result in infective phage particles without the need to swap the adaptor (gp11/
gp31) and nozzle (gp12/gp32) proteins between K11 and KP32. This can be explained by
the high identity of these proteins (97% [gp11/gp31] and 95% [gp12/gp32] at the amino
acid level) between K11 and KP32. Thus, the anchors of both viruses can be used
interchangeably.
Phage T7 encodes a single well-characterized RBP. At the time of the construction of
K11-T7 chimeras (33) and the phage K11 chimeras in this work, phage K11 also was
assumed to encode a single RBP. However, recent bioinformatic analyses revealed the
presence of a second putative RBP in phage K11 (NCBI accession no. YP_002003831.1).
This second RBP is predicted to dock on a T4gp10-like domain that comes immediately
after the anchor domain of the first RBP (16). Phage K11 was screened against a panel of
79 Klebsiella serotypes (see Table S5 in the supplemental material), but no susceptible
strain was found. The second RBP might have a capsular specificity not present in our col-
lection and may target lipopolysaccharide or even a proteinaceous receptor.
Alternatively, the enzymatic domain may have become inactivated due to mutations.
Therefore, it remains unknown whether the second RBP of phage K11 is incorporated in
the chimeric K11 phage particles. In this work, the predicted T4gp10-like domains are
part of the enzyme module of KP32gp37 (1E) and K11gp17 (5E), which may offer docking
sites for the second RBP of phage K11. However, KP32gp38 (2E), KP32gp57 (3E), and
KP36gp50 (4E) have no predicted T4gp10-like domain. The modified phages K115A2E and
K115A3E suggest that the incorporation of the second RBP is not essential to obtain infec-
tive phage particles. The same hypothesis is valid for phage K11 with gp11, gp12, and
gp17 from phage T7, as T7gp17 is also lacking a T4gp10-like domain.
The modular build-up of phage RBP structures with recyclable building blocks respon-
sible for the structural organization and receptor specificity, driven by intense horizontal
transfers, provides an evolutionary highway for the rapid adaptation to the high diversity
of K. pneumoniae capsules not necessarily constrained by taxonomic borders or different
RBP architectures. With the recent maturation of synthetic biology tools for phage design
(43–49), an increasing number of engineered phages can be constructed to gain further
meaningful insights in the host recognition system by Klebsiella phage RBPs and the role
of their domains in specificity and structural organization.
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Bacteriophages, bacterial hosts, yeast, and culture conditions. Klebsiella pneumoniae bacterio-
phages KP32 (GenBank accession no. NC_013647.1), KP34 (NC_013649.2), and KP36 (NC_029099.1) were
used from the collection of the Department of Pathogen Biology and Immunology, University of
Wroclaw, Poland, and K11 (NC_011043.1) from the collection of the Synthetic Biology Group,
Massachusetts Institute of Technology (Table 1). Podoviruses KP32 (and K11) and KP34 belong to sepa-
rate genera of the Autographiviridae family (Przondovirus and Drulisvirus, respectively), whereas siphovi-
rus KP36 belongs to the Webervirus genus of the Drexlerviridae family. All phages were plated using the
soft agar (0.5% agar in tryptic soy broth [TSB]; bioMérieux, Marcy l’Etoile, France) method (50), poured
on tryptic soy agar (TSA; bioMérieux, Marcy l’Etoile, France), and incubated for 18 h at 37°C. All Klebsiella
strains listed in Table 2 were cultured in TSB (bioMérieux) or on TSA (bioMérieux) at 37°C.
Escherichia coli strains used for plasmid propagation (TOP10; Invitrogen, Thermo Fisher Scientific,
Waltham, MA) and protein expression [BL21(DE3), Invitrogen] were grown in standard lysogeny broth
(LB; Biomaxima, Lublin, Poland) or on LB agar (LB supplemented with 1.5% bacteriological agar; VWR,
Radnor, PA, USA). E. coli TOP10 transformed with a pVTEIII entry vector was grown on LB supplemented
with 100mg/ml ampicillin (Fisher Scientific, Thermo Fisher Scientific, Waltham, MA) and 5% sucrose
(Fisher Scientific). E. coli TOP10 and BL21(DE3) transformed with a pVTD2 destination vector were grown
on LB supplemented with 50mg/ml kanamycin (Acros Organics, Thermo Fisher Scientific, Waltham, MA)
and 5% sucrose (Fisher Scientific). For LB cultures of E. coli TOP10 and BL21(DE3) transformed with
pEXP-5-CT/TOPO (Invitrogen), 100mg/ml ampicillin was added. For phage genome assembly by gap
repair cloning, Saccharomyces cerevisiae BY4741 (Thermo Scientific, Thermo Fisher Scientific, Waltham,
MA) was used. Yeast cells were cultured in standard YPD medium (1% Bacto yeast extract [Becton,
Dickinson, East Rutherford, NJ, USA], 2% Bacto peptone [Becton, Dickinson], 2% dextrose [VWR]) or in
synthetic complemented minimal medium (SC complete, containing YNB plus nitrogen, complete sup-
plement mixture [CSM]; Sunrise Science Products, Knoxville, TN) supplemented with 2% dextrose (VWR).
For the selection of YAC-positive cells, SC-Leu (YNB plus nitrogen, CSM-Leu; Sunrise Science Products)
supplemented with 2% dextrose (VWR) was used. A 2% agar supplementation was applied for solid me-
dium (yeast culture-grade agar; Sunrise Science Products). Yeast cells were grown at 30°C for 24 to 72 h.
For electroporation with phage genomes captured in a YAC, E. coli 10G (Lucigen, LGC Ltd., Teddington,
Great Britain) cells were used.
Plasmids. Tiles were cloned in the pVTEIII vector and subsequently assembled in the pVTD2 vector
(32). For cloning and expression of the coding sequences for the enzyme domains and anchor and trun-
cated RBPs, commercially available vectors pEXP-5-CT/TOPO and pEXP-5-NT/TOPO (Invitrogen) were
used. Some proteins (KP32gp37, KP32gp38, KP34gp57 and KP36gp50) have been cloned and expressed
before (8, 9, 31, 56). For synthetic assembly in yeast, the yeast centromere vector pRS415 with LEU2
marker (ATCC 87520) was used.
Construction of chimeric RBPs. The VersaTile technique was applied to make chimeric RBPs similar
to how the technique was used to construct chimeric lysins (32). The method follows a two-step
approach: (i) a repository of all building blocks (i.e., tiles) is created with VersaTile cloning, and (ii)
selected tiles are combined in a single assembly reaction using VersaTile shuffling (Fig. 1). Tiles were pre-
pared by PCR using Phusion DNA polymerase (Thermo Fisher Scientific, Waltham, MA) and specifically
designed primers (see Table S1 in the supplemental material). The flanking position tags determine the
position of the tile in the final assembly. Gel extraction of the amplicons was performed using the
GeneJET gel extraction kit (Thermo Fisher Scientific). Subsequently, the purified amplicons were inserted
into the entry vector pVTEIII by type IIs cloning (SapI/T4 DNA ligase). The tile encoding a hexahistidine
TABLE 1 Phages used in this study





KP32 NC_013647.1 Autographiviridae, Studiervirinae, Przondovirus DPBI UWr K3, K21 271, 358, 968
KP34 NC_013649.2 Autographiviridae, Slopekvirinae, Drulisvirus DPBI UWr K63 77, 486
KP36 NC_029099.1 Drexlerviridae,Webervirus DPBI UWr K63 77, 486
K11 NC_011043.1 Autographiviridae, Studiervirinae, Przondovirus SBG MIT K11 390
aDPBI UWr, Department of Pathogen Biology and Immunology, University of Wroclaw, Poland. SBG MIT, Synthetic Biology Group, Massachusetts Institute of Technology.
TABLE 2 K. pneumoniae strains used in this study
Klebsiella strain Sourcea Capsular serotype Phage susceptibility
K. pneumoniae 271 DPBI UWr K3 KP32
K. pneumoniae 390 SBG MIT K11 K11
K. pneumoniae 358 DPBI UWr K21 KP32
K. pneumoniae 968 DPBI UWr K21 KP32
K. pneumoniae 77 DPBI UWr K63 KP34, KP36
K. pneumoniae 486 DPBI UWr K63 KP34, KP36
aDPBI UWr, Department of Pathogen Biology and Immunology, University of Wroclaw, Poland. SBG MIT,
Synthetic Biology Group, Massachusetts Institute of Technology.
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purification tag was prepared by cassette hybridization. Briefly, a mixture of primers (His tag F and R;
Table S1) was incubated for 2min at 95°C and then gradually cooled down. Pfu polymerase (Thermo
Fisher Scientific) was added (10min at 72°C) to fill in the single overhanging strands. The cassette was
purified using the GeneJET PCR purification kit (Thermo Fisher Scientific) and inserted into the pVTEIII
entry vector as described above. Present BsaI recognition sites in the coding sequences of tiles were
mutated before using specific primers (Table S1). In these cases, the tile of interest was assembled from
two (KP34gp57; 3E) or three (KP36gp50; 4E) amplicons in one restriction (SapI)/ligation (T4 DNA ligase)
reaction, simultaneously inserting the assembled sequence in the pVTEIII entry vector. After enzyme
inactivation of the assembly reaction (50°C for 5min and 65°C for 20min), restriction/ligation mixtures
were used for the transformation of chemocompetent E. coli TOP10 cells by heat shock. Positive con-
structs, verified by colony PCR, were Sanger sequenced by LGC Genomics (Berlin, Germany) using appro-
priate primers (Table S1). Plasmid DNA of tiles ready for a VersaTile shuffling reaction was isolated from
overnight cultures using the GeneJET plasmid miniprep kit (Thermo Fisher Scientific). For the assembly
reaction, a tile for positions 1, 2, and 3 (each 50 ng) and pVTD2 (100 ng) vector were added to a mixture
of BsaI (10 U), T4 DNA ligase (1 U), 10 ligation buffer, and ultrapure water (total volume of 20ml). Fifty
cycles of restriction/ligation were conducted (2min at 37°C and 3min at 16°C) followed by enzyme inac-
tivation for 5min at 50°C and 5min at 80°C. Restriction/ligation mixtures were used for the transforma-
tion of chemocompetent E. coli TOP10 cells by heat shock. Correct plasmids verified by Sanger sequenc-
ing were used for E. coli BL21(DE3) transformation for chimeric protein expression.
Cloning of coding sequences of reference depolymerase domains and anchor and truncated
RBPs. Coding sequence fragments were amplified by PCR (Table S1) with Pfu DNA polymerase (Thermo
Fisher Scientific), followed by postamplification 39 A-overhang addition by DreamTaq polymerase
(Thermo Fisher Scientific). Subsequently, amplicons were cloned into the pEXP-5-CT/TOPO vector
(Invitrogen) with a C-terminal histidine tag according to the manufacturer's conditions. Transformation
of chemocompetent E. coli TOP10 cells for plasmid propagation and isolation was followed by Sanger
sequencing. Corrected constructs were used for E. coli BL21(DE3) transformation and subsequent protein
expression.
Protein expression and visualization. The recombinant E. coli BL21(DE3) cells were grown in LB
supplemented with appropriate antibiotic at 37°C with agitation until the optical density at 600 nm
reached 0.5. The culture was induced by the addition of 0.1mM isopropyl-b-D-thiogalactopyranoside
(IPTG; Bio-Connect BV), followed by 18 h of incubation at 20°C. Cultures were pelleted by centrifugation
(5,000 g, 10min, 4°C), resuspended in lysis buffer containing 20mM NaH2PO4-Na2HPO4 (Acros
Organics), 0.5 M NaCl (Acros Organics), pH 7.4, and lysed by three cycles of freeze-thawing followed by
sonication. For spot tests, cell lysate was used. For analysis of protein fractions, SDS-PAGE (180 V for
approximately 1 h) was performed with 12% polyacrylamide gels (51). Coomassie brilliant blue R-250
(Bio-Rad, Hercules, CA, USA) staining was applied for protein visualization.
Activity spot test and specificity analysis. Bacterial lawns were prepared by pouring 1ml of over-
night Klebsiella culture on TSA plates. Ten microliters of cell lysate was spotted on a dried bacterial lawn
with 10ml of lysis buffer and BL21(DE3) lysate (with an empty plasmid) as controls. Plates were incu-
bated at 37°C overnight.
Phage engineering. Phage engineering was performed by gap-repair cloning in S. cerevisiae, with
some modifications (33). KAPA HiFi DNA polymerase (Kapa Biosystems, Roche, Basel, Switzerland) was
used to amplify phage genome fragments with overlapping ends, including the intended genome modi-
fication (Table S1). The first and last phage genome fragments were equipped with sequences homolo-
gous to the termini of linearized YAC. PCR products were used as such for further steps of genome as-
sembly. To produce the linearized YAC vector, the shuttle YAC vector pRS415 (propagated in E. coli
TOP10) was digested by PvuII (New England BioLabs, Ipswich, MA) and XbaI (New England BioLabs). The
fragment (2,910 nt long) enabling propagation in yeast cells (CEN/ARS) and selection (LEU2, LEU2 pro-
moter) was amplified with KAPA HiFi DNA polymerase using specific primers (Table S1) and digested by
DpnI (New England BioLabs), and the amplicon was purified by gel extraction (Zymoclean gel DNA re-
covery; Zymo Research, Freiburg im Breisgau, Germany).
Competent S. cerevisiae BY4741 cells were prepared as described previously (33). PCR amplicons cov-
ering the phage genome, including the fragment corresponding to the genome modification, were
mixed in equal concentrations. The PCR amplicon mixture (Table S2) and 20ng of linear YAC fragment
was added to competent cells. The mixture was vortexed, followed by a 45-min-long incubation at 42°C
and centrifugation (13,000 g; 30 s). Transformed cells were resuspended in 200ml SC complete, incu-
bated for 1 h at 30°C, plated on SC-Leu, and grown at 30°C for 72 h.
Precultures of successful transformants were started from single colonies in 5ml of SC-Leu and incu-
bated at 30°C for 72 h. DNA extraction was performed according to the manufacturer’s instructions
using the YeaStar genomic DNA kit (Zymo Research). Extracted DNA was used for electroporation of
25ml E. coli 10G cells (2-mm-gap electroporation cuvette [Bio-Rad]; standard settings were 2.5 kV, 25 mF,
200 X; Gene Pulser Xcell [Bio-Rad]). Cells were immediately recovered into 1ml of SOC medium
(Lucigen) and incubated at 37°C for 3 h with agitation. To kill the cells and to release the rebooted
phages, 100ml chloroform (VWR) was added, followed by vortexing and spinning down. Supernatant
(0.5ml) was mixed with 200ml of the appropriate logarithmically growing host strain (Table 2) in 3ml
top agar (TSB and 0.5% agar, 55 to 60°C) and plated on TSA. Plates were checked for plaques after incu-
bation at 37°C for 18 h.
Attempts were undertaken to produce recombinant phage K115A4E using Gibson assembly (Gibson
assembly master mix; NEB) for genome construction covered by 6 fragments (Tables S1 and S2) as
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described before (52, 53), followed by E. coli 10G electroporation, but no infective phage particles were
observed.
Data availability. All supporting data, sequences, and accession numbers are available in the sup-
plemental material.
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